Acquisition
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
PCI Pharma Services
PR-04-25-NI-05Apr 24, 2025
Acquirement
Lilly to Acquire Scorpion Therapeutics' Mutant-Selective PI3Kα Inhibitor Program
Eli Lilly and Company
PR-01-25-NI-14Jan 14, 2025
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13Oct 25, 2024
Financing
Why Life Science Companies Surged amid a Global M&A Downturn
Amanda Wang
That's Nice LLC
PAO-10-24-CL-11Oct 15, 2024
M&A
Olon Continues its Growth Path and Announces a New Acquistion
Olon
PR-09-24-NI-01Sep 04, 2024
Cell Therapy
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
Genezen
PR-07-24-NI-01Jul 02, 2024
Vantage Nutrition LLC Acquires ComboCap Inc
Vantage Solutions
PR-M03-23-07Mar 27, 2023
M&A
Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement
Pluristyx
PR-M10-22-04Oct 06, 2022
Integration
Actylis Debuts, Signaling the Creation of an Integrated Global Specialty Ingredients Manufacturing and Sourcing Powerhouse
Actylis
PR-M09-22-06-262Sep 26, 2022
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01Sep 07, 2022
Audit Service Merger
Merger of Rephine with Forum Auditorias & TDV Creates Clear Market Leader in Global GMP Audit Services
Rephine
PR-M07-22-01Jul 06, 2022
M&A
ProductLife Group Strengthens Foothold in Northern Europe with Pharma IT Acquisition
ProductLife Group
PR-M06-22-08Jun 30, 2022
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Nigel Walker
Nice Insight
PAO-06-022--NI-12Jun 24, 2022
M&A
Growing a Forward-Thinking CDMO
CoreRx
PAO-04-22-R250-78May 04, 2022
M&A
Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer
Novo Holdings A/S
PR-M04-22-05Apr 07, 2022
M&A
Incannex to Acquire APIRx Pharmaceuticals USA, LLC
Incannex Healthcare Limited
PR-M03-22-12Mar 24, 2022
Column: M&A
Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game
Nigel Walker
Nice Insight
PAO-03-022-NI-08Mar 23, 2022
M&A
Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform
Ginkgo Bioworks
PR-M03-22-05Mar 14, 2022
CDMO Acquisition
Vibalogics Acquired by Top Global CDMO Recipharm AB
Vibalogics
PR-M02-22-18Feb 18, 2022
CDMO Acquisition
Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand its Biologics Offering in the U.S.
Recipharm AB
PR-M02-22-17Feb 18, 2022